Pfizer to buy Biohaven Pharmaceutical for $11.6 billion Pfizer said it will buy migraine drug maker Biohaven Pharmaceutical Holding Company for about $11.6 billion in cash, as the drugmaker seeks to beef up … Business • 10 May 22
Allergan's migraine treatment wins US FDA approval The US Food and Drug Administration has approved Allergan drug for relieving migraine headaches after their onset. Business • 24 Dec 19
Migraines possible indicator of heart problems - study A 19-year investigation involving more than half a million people has suggested that suffering with migraines could indicate underlying heart problems. Health • 01 Feb 18
